09 May, 2024

Karam named head of radiation oncology department – ​​Washington University School of Medicine in St. Louis

Visit the News Hub Innovative physician-scientist specializing in head and neck, pancreatic cancers also known as influential mentor Courtesy of Sana Karam Sana D. Karam, MD, PhD, has been named the James S. McDonnell Professor of Radiation Oncology and head of the Department of Radiation Oncology at Washington University School of Medicine in St. Louis. […]

9 mins read

How did Buro Happold shape the future of a new medical school?

Buro Happold strategy specialists were key advisors for a new medical school in Charlotte, North Carolina. Learn how our experts shaped the future of Wake Forest University School of Medicine. Our strategy and operating model design advisors, working in partnership with Wake Forest University School of Medicine and Atrium Health, developed the spatial and facilities […]

10 mins read

Icahn School of Medicine at Mount Sinai Names Miriam Merad, MD, PhD, as Dean for Translational Research and Therapeutic Innovation

Newswise — New York, NY [April 29, 2024]—Miriam Merad, MD, PhD, a world-renowned immunologist, has been appointed Dean for Translational Research and Therapeutic Innovation of the Icahn School of Medicine at Mount Sinai. The appointment reaffirms Icahn Mount Sinai’s commitment to pioneering medical progress and catalyzing the rapid advancement of research innovation. Dr. Merad, the […]

9 mins read

Atossa Therapeutics Announces Expanded Research Agreement

SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced an expanded research agreement with Weill Cornell Medicine to explore the potential synergy between antibody drugs conjugates (ADCs) and (Z)-endoxifen. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need […]

8 mins read

Prime Medicine Announces FDA Clearance of Investigational

First-Ever Open IND for Prime Editing Technology PM359 is Prime Medicine’s Ex Vivo Product Candidate Designed to Correct a Prevalent Disease-Causing Mutation of CGD Initial Data Expected in 2025 CAMBRIDGE, Mass., April 29, 2024 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated, one-time curative […]

9 mins read

The health risks of generative AI-based wellness apps

Catsaros, O. Generative AI to become a $1.3 trillion market by 2032, research finds. Bloomberg https://www.bloomberg.com/company/press/generative-ai-to-become-a-1-3-trillion-market-by-2032-research-finds/ (1 June 2023). Kanagaraj, M. Here’s why mental healthcare is so unaffordable & how COVID-19 might help change this. Harvard Medical School Primary Care Review https://info.primarycare.hms.harvard.edu/review/mental-health-unaffordable (2020). Terlizzi, EP & Schiller, JS Mental health treatment among adults aged 18–44: […]

7 mins read

2024-04 – Science meets history at Adler Museum of Medicine

April 29, 2024 – Wits University Exhibition celebrates the life and scientific journey of Nobel Laureate and alumnus Sydney Brenner. Professor Sydney Brenner (1927-2019) was a molecular biologist best known for explaining how DNA encodes the message to make proteins, which are the building blocks of cells and ultimately […]

8 mins read